Agostino C.
- Country
- Italy
- Department
- Dipartimento endocrinologia e malattie metaboliche
Research Overview
- Efficacy and Safety Assessment of Finerenone and Empagliflozin Combination Versus Monotherapy in Chronic Kidney Disease with Type 2 Diabetes
- Intraclass Safety and Efficacy Evaluation of SGLT2 Inhibitors in Elderly Patients with Type 2 Diabetes: A Phase IV Multicenter Randomized Controlled Trial
- Efficacy and Safety of Colchicine and Carbaspirin Calcium in Cardiovascular Outcomes for Type 2 Diabetes Patients Without Prior Cardiovascular Events
Data & Insights
Has run more than one trial at 13 of 115 partner sites.
Specializations
Diabetes Management
The investigator specializes in treating type 2 diabetes mellitus with particular emphasis on innovative therapeutic approaches and cardiovascular risk management.
- Novel diabetes medications
- Glycemic control optimization
- Diabetes in elderly populations
Their research extends to evaluating emerging treatment options, including GLP-1 receptor agonists and SGLT2 inhibitors.
Cardiovascular Health
Focus areas include cardiovascular disease prevention in diabetic patients and the assessment of therapeutic interventions for reducing major adverse cardiovascular events.
- Cardiovascular risk assessment
- Preventive cardiology
- Anti-inflammatory approaches
Their work involves investigating the relationship between diabetes complications and cardiovascular outcomes.
Renal Medicine
The investigator has significant expertise in studying chronic kidney disease in both type 1 and type 2 diabetes patients.
- Diabetic nephropathy
- Renal protection strategies
- Combination therapy approaches
Research includes evaluation of novel therapeutic agents for kidney protection in diabetic patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.